|Bid||39.57 x 800|
|Ask||44.97 x 1100|
|Day's range||38.94 - 39.74|
|52-week range||28.03 - 48.50|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||54.00|
Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LEWISVILLE, Texas, July 28, 2021--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it plans to release financial results for the second quarter 2021 before market open on Friday, August 6, 2021. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m. ET the same day.
LEWISVILLE, Texas, July 28, 2021--Orthofix launches the fiberFUSE™ Strip, a preformed bone-graft optimized for posterior cervical, posterior lumbar and degenerative spinal procedures.